Brief: Imdx Welcomes New VP Marketing To Prepare For Commercial Transplant Assay Launch
13/10/2025 21:18
Oct 13 (Reuters) - Insight Molecular Diagnostics Inc IMDX.O: IMDX WELCOMES NEW VP MARKETING TO PREPARE FOR COMMERCIAL TRANSPLANT ASSAY LAUNCH Source text: ID:nGNX77nZY0 Further company coverage: IMDX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission